Univ.-Prof. Dr. Gerald Gartlehner, MPH

Danube University Krems

Gerald Gartlehner

Projects (Extract Research Database)

Publications (Extract Research Database)

Affengruber, L.; Wagner, G.; Waffenschmidt, S.; Lhachimi S.K.; Nussbaumer-Streit, B.; Thaler, K.; Griebler, U.; Klerings, I.; Gartlehner, G. (2020). Combining abbreviated literature searches with single-reviewer screening: three case studies of rapid reviews. Systematic Reviews, 9(1):162.: doi:10.1186/s13643-020-01413-7

Chevance, A.; Ravaud, P.; Tomlinson, A.; Le Berre C.; Teufer, B.; Touboul, S.; Fried, E.I.; Gartlehner, G.; Cipriani, A.; Thi Tran, V.; (2020). Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international online survey. The Lancet Psychiatry, Volume 7, Issue 8: 692-702

Gartlehner, G.; Affengruber, L.; Titscher, V.; Noel-Storr, A.; Dooley, G.; Ballarini, N.; König, F. (2020). Single-reviewer abstract screening missed 13 percent of relevant studies:a crowd-based, randomized controlled trial. Journal of Clinical Epidemiology, 121: 20-28

Mayr, V.; Nussbaumer-Streit, B.; Gartlehner, G. (2020). Quarantäne alleine oder in Kombination mit weiteren Public-Health-Maßnahmen zur Eindämmung der COVID-19 Pandemie: Ein Cochrane Rapid Review. Gesundheitswesen, https://doi.org/10.1055/a-1164-6611: https://doi.org/10.1055/a-1164-6611, Georg Thieme Verlag KG Stuttgart · New York

Nussbaumer-Streit, B.; Klerings, I.; Dobrescu, A.I.; Persad, E.; Stevens, A.; Garritty, C.; Kamel, C.; Affengruber, L.; King, V.J.; Gartlehner, G. (2020). Excluding non-English publications from evidence-syntheses did not change conclusions: a meta-epidemiological study. Journal of Clinical Epidemiology, 118: 42-54

Nussbaumer-Streit, B.; Klerings, I.; Gartlehner, G. (2020). Reply to letter to the editor ‘Lessons from COVID-19 to Future Evidence Synthesis Efforts: First Living Search Strategy and Out of Date Scientific Publishing and Indexing Industry. Journal of Clinical Epidemiology, In Press, Journal Pre-proof: https://doi.org/10.1016/j.jclinepi.2020.04.013

Nussbaumer-Streit, B.; Mayr, V.; Dobrescu, A.I.; Chapman, A.; Persad, E.; Klerings, I.; Wagner, G.; Siebert, U.; Christof, C.; Zachariah, C.; Gartlehner, G.; (2020). Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database of Systematic Reviews, Issue 4: Art. No.: CD013574.

Pfinder, M.; Heise, T.L.; Hilton Boon, M.; Pega, F.; Fenton, C.; Griebler, U.; Gartlehner, G.; Sommer, I.; Katikireddi, S.V.; Lhachimi, S.K. (2020). Taxation of unprocessed sugar or sugar-added foods for reducing their consumption and preventing obesity or other adverse health outcomes. Cochrane Database of Systematic Reviews, Issue 4: Art. No.: CD012333.

Sommer, I.; Teufer, B.; Szelag, M.; Nussbaumer-Streit, B.; Titscher, V.; Klerings, I.; Gartlehner, G. (2020). The performance of anthropometric tools to determine obesity: a systematic review and meta-analysis. Scientfic Reports. natureresearch, 10: 12699

Wagner, G.; Stollenwerk, H.K.; Klerings, I.; Pecherstorfer, M.; Gartlehner, G.; Singer, J. (2020). Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review. OncoImmunology, VOL. 9, NO. 1: 1-16

Ebenberger, A.; Nussbaumer-Streit, B.; Teufer, B.; Langer, G.; Schwingshackl, L.; Töws, I.; Gartlehner, G. (2020). GRADE-Leitlinien zu Gerechtigkeit 3: Berücksichtigung der Gerechtigkeit im Gesundheitswesen bei der Entwicklung von GRADE-Leitlinien: Vertrauenswürdigkeit der Evidenz beurteilen. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, In Press: https://doi.org/10.1016/j.zefq.2020.06.001

Morche, J.; Freitag, S.; Hoffmann, F.; Rissling, O.; Langer, G.; Nussbaumer-Streit, B.; Toews, I.; Gartlehner, G.; Meerpohl, J.J. (2020). GRADE-Leitlinien: 18. Wie ROBINS-I und andere Instrumente zur Einschätzung des Risikos für Bias von nicht-randomisierten Studien verwendet werden sollten, um die Vertrauenswürdigkeit eines Evidenzkörpers zu bewerten. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, in press: in press

Christof, C.; Nussbaumer-Streit, B.; Gartlehner, G. (2019). Risikokommunikation in gesundheitsbedrohlichen Krisensituationen: Zusammenfassung einer WHO-Leitlinie. Gesundheitswesen, 81(10): 846-849

Donahue, K.E.; Schulman, E.R.; Gartlehner, G.; Jonas, B.L.; Coker-Schwimmer, E.; Patel, S.V.; Palmieri Weber, R.; Bann, C.M.; Viswanathan, M. (2019). Comparative Effectiveness of Combining MTX with Biologic Drug Therapy Versus Either MTX or Biologics Alone for Early Rheumatoid Arthritis in Adults: a Systematic Review and Network Meta-analysis. J Gen Intern Med, Epub ahead of print: doi: 10.1007/s11606-019-05230-0.

Forneris, C.A.; Nussbaumer-Streit, B.; Morgan, L.C.; Greenblatt, A.; Van Noord M.G.; Gaynes, B.N.; Wipplinger, J.; Lux, L.J.; Winkler, D.; Gartlehner, G. (2019). Psychological therapies for preventing seasonal affective disorder (Review). Cochrane Database of Systematic Reviews, Issue 5: Art. No.: CD011270.

Gartlehner, G.; Nussbaumer-Streit, B.; Gaynes, B. N.; Forneris, C. A.; Morgan, L. C.; Greenblatt, A.; Wipplinger, J.; Lux, L. J.; Van Noord, M. G.; Winkler, D. (2019). Second-generation antidepressants for preventing seasonal affective disorder in adults. Cochrane Database Syst Rev, 3: 10.1002/14651858.CD011268.pub3

Gartlehner, G.; Nußbaumer-Streit, B.; Wagner, G.; Patel, S.; Swinson-Evans, T.; Dobrescu, A; Gluud, C.; (2019). Increased risks for random errors are common in outcomes graded as high certainty of evidence. Journal of Clinical Epidemiology, 106: 50-59

Gartlehner, G.; Wagner, G.; Lux, L.; Affengruber, L.; Dobrescu, A.; Kaminski-Hartenthaler, A.; Viswanathan, M. (2019). Assessing the accuracy of machine-assisted abstract screening with DistillerAI: a user study. Systematic Reviews, 8:277: https://doi.org/10.1186/s13643-019-1221-3

Gaynes, B.N.; Lux, L.; Gartlehner, G.; Asher, G.; Forman-Hoffman; V.; Green, J.; Boland, E.; Weber, R.P.; Randolph, C.; Bann, C.; Coker-Schwimmer, E.; Viswanathan, M.; Lohr, K.N. (2019). Defining treatment-resistant depression. Depress Anxiety, [Epub ahead of print]: 1-12/DOI: 10.1002/da.22968

Majoie, H. J. M.; van Gaalen, J.; Verstegen, D. M. L.; van Mastrigt, G. A. P. G.; Kleijnen, J.; Alonso-Coello, P.; Gartlehner, G.; Ritchie, K.; Service, D.; Leone, M.; Evers, S. M. A. A. (2019). Cost-conscious high-quality care and guideline development education: a strange contradiction or simple solution? European Journal of Neurology, 26: 10.1111/ene.13855

Load more

Lectures (Extract Research Database)

Targeted Immune Modulators for Rheumatoid Arthritis and Ankylosing Spondylitis.

Online Präsentation für das Washington State P&T Committee Meeting, 17/06/2020

Cochrane Rapid Reviews - a response to COVID-19

AHRQ Evidence-based Practice Center Spring Meeting, 04/06/2020

The accuracy of single- vs. dual-reviewer abstract screening: a crowd-based randomized controlled trial.

21. Jahrestagung EbM-Netzwerk 2020, 14/02/2020

Point-of-care Ultrasonography for Acute Dyspnea. A Systematic Review and Meta-analysis.

Meeting of the American College of Physicians Guideline Panel, Philadelphia, USA, 29/01/2020

"Evidence-based Medicine can harm your health" - Cochrane Austria's battle against fake health news.

Herbstseminar d. Wiener Biometrischen Sektion: "Update in Evidence Synthesis Methods - Current Topics in Meta-analysis", Medical University Vienna, Ö., 13/11/2019

Screening for hypertension in children and adolescents.

Meeting of the United States Preventive Services Task Force, Bethesda, USA, 30/10/2019

VU 2020 Empfehlungen des ExpertInnengremiums

Hauptverband der österreichischen Sozialversicherungsträger, Sitzung der leitenden ÄrztInnen, Wien, Österreich, 25/07/2019

Does the pill against lovesickness work? Responding to inquiries from the general public with existing evidence

Evidence Live, Oxford, UK, 15/07/2019

Evidence-based Decision Making

Workshop beim 5th Congress of the European Academy of Neurology, Oslo, Norway, 28/06/2019

Assessing the accuracy of machine-assisted abstract screening with DistillerAI.

Agency for Healthcare Research and Quality EPC V Panel Meeting, Rockville, MD, USA, 07/06/2019

Evidence-based Medicine - ein kritischer Diskurs

Jahrestagung der Österreichischen Akademie für Dermatologische Fortbildung, Graz, Österreich, 30/05/2019

Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors

Webpräsentation; Idaho P&T Committee Meeting, 19/04/2019

Interessenskonflikte bei ÄrztInnen: Wie die Industrie ärztliche Entscheidungen beeinflusst

Sceptics in the Pub, Wien, Österreich, 20/03/2019

Interessenskonflikte bei Ärztinnen und Ärzten: Wie die Industrie medizinische Entscheidungen beeinflusst.

GÖG Symposium, Wien, Österreich, 27/02/2019

VU2020: Methoden der Überarbeitung

VORSORGEUNTERSUCHUNG. Ergebnisse des Evidenz-Updates, Wien Österreich, 30/01/2019

Formulating Questions, Selecting Outcomes and Introduction to the Guideline Development Tool

GRADE Workshop, World Health Organisation, Genf, Schweiz, 10/01/2019

MSc in Public Health - Comparative Effectiveness Research. Module 10: CER Case Studies

Universite Paris Descartes, Paris, Frankreich , 10/12/2018

Interessenskonflikte: Wie die Industrie ärztliche Entscheidungen beeinflusst

Verband der leitenden Krankenhausärzte Österreichs, Kunsthistorisches Museum, Wien, Österreich, 28/11/2018

Interessenskonflikte bei Ärzten: Wie die Industrie ärztliche Entscheidungen beeinflusst.

Ordensklinikum Linz GmbH, Barmherzige Schwestern, Linz, Österreich, 26/11/2018

Increased risks of false-positive or false-negative findings are common in outcomes graded as high certainty of evidence

25th Cochrane Colloquium Edinburgh, Großbritannien, 18/09/2018

Load more
Back to top


To Glossary

This website uses cookies to improve your user experience and for analytical purposes for optimizing our systems, as well Google Maps for the use of depicting maps. By clicking on „OK" or continuing to browse the site, you are agreeing to the use of cookies and Google Maps. More information concerning privacy policy and data protection official.